Korean Society of Thyroid Radiology (KSThR) guidelines for the management of pediatric thyroid nodules: Suitability and risk factors

医学 指南 甲状腺 甲状腺结节 恶性肿瘤 放射科 活检 人口 结核(地质) 甲状腺癌 细针穿刺 内科学 病理 古生物学 环境卫生 生物
作者
Seul Bi Lee,Yeon Jin Cho,Seunghyun Lee,Young Hun Choi,Jung‐Eun Cheon,Woo Sun Kim
出处
期刊:Thyroid [Mary Ann Liebert]
被引量:6
标识
DOI:10.1089/thy.2020.0875
摘要

Background: The guideline for managing pediatric thyroid nodules has not been established. We investigated the appropriateness of the Korean Society of Thyroid Radiology (KSThR) guidelines and the need to consider risk factors for managing pediatric thyroid nodules. Methods: From August 2007 to February 2020, a database of thyroid nodules in patients younger than 19 years who underwent fine-needle aspiration (FNA) was analyzed. Two radiologists retrospectively reviewed ultrasound images to characterize the nodules according to the Korean Thyroid Imaging Reporting and Data System (K-TIRADS) criteria. Thyroid nodules were divided into benign and malignant nodules. Clinical risk factors were identified, including familial thyroid cancer, history of radiation therapy, and underlying thyroiditis. According to the K-TIRADS categories and the presence of risk factors, malignancy rates were calculated. We compared the diagnostic performance of the original KSThR guidelines and newly suggested criteria for FNA derived by simulation tests with variable size cutoffs in the total study population, a group with risk factors, and a group without risk factors. Results: A total of 107 patients (mean age, 13.9 years; range, 4-18 years; 83 females; 50 patients with risk factors) with 133 nodules (71 benign and 62 malignant) were included. The malignancy rate of thyroid nodules was higher in the group with risk factors (64.0%) than in the group without risk factors (43.9%; p = 0.037). Compared with the KSThR guideline (≥1.0 cm for K-TIRADS 4 and 5), the accuracy was higher (62.4% vs. 56.4%) and the unnecessary biopsy rate was lower (44.0% vs. 47.4%) when the new criteria (≥0.6 cm for K-TIRADS 4 and ≥0.5 cm for K-TIRADS 5) were used in the total study population. In particular, in the group with risk factors, the newly suggested size criteria had a much higher accuracy (73.1% vs. 59.7%) and lower unnecessary biopsy rate (30.4% vs. 35.5%) than the KSThR guideline. Conclusions: For the management of thyroid nodules in children, it is necessary to consider risk factors and adjust the criteria values for FNA. FNA should be considered in children with risk factors for thyroid cancer even if thyroid nodules are small.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ANDW完成签到 ,获得积分10
刚刚
Kotory完成签到,获得积分10
2秒前
2秒前
Murphy~完成签到,获得积分10
3秒前
zyfxxh发布了新的文献求助30
7秒前
ce完成签到,获得积分10
8秒前
拾个勤天完成签到,获得积分10
8秒前
PORCO完成签到,获得积分10
9秒前
penxyy应助wangxiaoyanger采纳,获得10
11秒前
12秒前
THEODLL完成签到,获得积分10
16秒前
谨慎纸飞机完成签到,获得积分10
17秒前
Chris完成签到 ,获得积分0
18秒前
夕杳完成签到,获得积分10
21秒前
lucia5354完成签到,获得积分0
21秒前
铁头霸霸完成签到 ,获得积分10
23秒前
勤恳的隶完成签到,获得积分10
23秒前
姜姜完成签到,获得积分10
23秒前
沐风完成签到,获得积分20
24秒前
臻灏完成签到,获得积分10
24秒前
濮阳盼曼完成签到,获得积分10
26秒前
小彬发布了新的文献求助30
26秒前
dj完成签到,获得积分10
28秒前
yy完成签到,获得积分10
29秒前
nssanc完成签到,获得积分10
30秒前
慕容飞凤完成签到,获得积分10
30秒前
鹰击长空完成签到,获得积分10
31秒前
科研通AI6.1应助SARAH采纳,获得10
31秒前
QYQ完成签到 ,获得积分10
31秒前
mymEN驳回了橘x应助
34秒前
开心向真完成签到,获得积分10
34秒前
自行迭代完成签到,获得积分10
35秒前
WENS完成签到,获得积分10
35秒前
苗条盼山完成签到,获得积分10
37秒前
瘦瘦安梦完成签到,获得积分10
37秒前
凉风送信完成签到,获得积分10
38秒前
顾矜应助lt0217采纳,获得10
39秒前
槿曦完成签到 ,获得积分10
42秒前
tuzi完成签到,获得积分10
42秒前
44秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Propeller Design 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6013344
求助须知:如何正确求助?哪些是违规求助? 7581682
关于积分的说明 16140309
捐赠科研通 5160581
什么是DOI,文献DOI怎么找? 2763400
邀请新用户注册赠送积分活动 1743418
关于科研通互助平台的介绍 1634331